The Mitralign transcatheter direct mitral valve annuloplasty system

EuroIntervention

Volumn 11, Issue , 2015, Pages W62-W63

  Nickenig, Georg ^a   Hammerstingl, Christoph ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL;

ANTICOAGULATION; CATHETER REMOVAL; CAUSE OF DEATH; CEREBROVASCULAR ACCIDENT; CLINICAL EFFECTIVENESS; FUNCTIONAL MITRAL VALVE REGURGITATION; GUIDE WIRE; GUIDING CATHETER; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HUMAN; MITRAL ANNULOPLASTY; MITRAL ANNULUS; MITRAL VALVE; MITRAL VALVE REGURGITATION; MITRAL VALVULOPLASTY CATHETER; PHASE 2 CLINICAL TRIAL (TOPIC); PLEDGET DELIVERY CATHETER; POSTOPERATIVE CARE; SAFETY; SHORT SURVEY; SURGICAL TECHNIQUE; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRANSCATHETER DIRECT MITRAL VALVE ANNULOPASTY; TREATMENT DURATION; ADVERSE EFFECTS; DEVICES; ECHOGRAPHY; HEART CATHETER; HEART CATHETERIZATION; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HEMODYNAMICS; MITRAL VALVE INSUFFICIENCY; PATHOPHYSIOLOGY; PATIENT SELECTION; PROCEDURES; PROSTHESIS DESIGN; RISK FACTOR; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TREATMENT OUTCOME;

CARDIAC CATHETERIZATION; CARDIAC CATHETERS; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEMODYNAMICS; HUMANS; MITRAL VALVE; MITRAL VALVE ANNULOPLASTY; MITRAL VALVE INSUFFICIENCY; PATIENT SELECTION; PROSTHESIS DESIGN; RISK FACTORS; TREATMENT OUTCOME;

EID: 84943151235     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV11SWA17     Document Type: Short Survey

References (2)

1. Nickenig G. Evaluation of the Mitralign Percutaneous Annuloplasty System for the treatment of FMR 6-month results. Abstracts EuroPCR. EuroPCR, Paris, France, May 2015.
2. Schofer J, Bijuklic K, Tiburtius C, Hansen L, Groothuis A, Hahn RT. First-in-human transcatheter tricuspid valve repair in a patient with severely regurgitant tricuspid valve. J Am Coll Cardiol. 2015;65:1190-5.